Researchers Study Effectiveness of Moble Apps for Mentally Ill
Technology overarches most everything we do in life, and with the invention of the smartphone, were even more engrossed in technologyfrom the way we get our news or entertainment to the way we connect with our colleagues and peers.
Certain phone applications even help us count calories or remind us to take our medications.
Now, UC researchers in the department of family and community medicine have been awarded a $24,547 grant from the Ohio Colleges of Medicine Governmental Resource Center to study the effectiveness of mobile health devices for Medicaid recipients with severe mental illness.
Research Professor Charles Doarn and Research Assistant Professor Joshua Magee, PhD, will identify and evaluate the mobile applications available to this subgroup of patients to assess their feasibility and use, eventually hoping to gain funding for a larger study to determine which are most beneficial.
"Mobility in medicine is not a new or recent phenomenon; however, it has only been recently that the application and utilization of cellular phones and mobile devices has taken off and has provided a unique opportunity for health care and access to knowledge available at our fingertips, says Doarn, who is the principal investigator on the study.
"Since we have experienced a worldwide adoption and integration of mobile phones in daily life, there has been a rapidly expanding market for applications in health, and research has already demonstrated the utility of mobile technology in psychiatry and psychology in the treatment of disease.
He continues that a current assessment has shown that there may be more than 4,000 applications for mental health for use on the iPhone and that Google searches of key terms like "telemental health and cell phones yield over 16,000 results.
"It is clear that a significant effort is underway to develop, adapt, adopt and integrate simple tools in a cost-effective manner for the entire continuum of health care, and mobile health adds value to mental health patients as these tools translate services to patients everyday lives in appealing, accessible and personalized ways, regardless of their location, he says. "In this study, we hope to find which tools work best and determine the cost-effectiveness of their use with hopes of better managing their illness and saving the health care system money.
Doarn says his team will review databases of current applications throughout the state of Ohio and existing scientific literature to find out what does and does not work for patients. He says the report will even be as detailed to determine which tools are being used in specific counties to determine what is beneficialand cost-effective in terms of lost productivity and unnecessary travel costsfor different populations within the state.
"After collecting this data, we will discuss various platforms and how they can be integrated into other public health concerns so that communities across all 88 counties in Ohio are involved and collaborating, he says. "This is just one piece in the whole telemedicine spectrum, and we need to think about the way medicine will change with these smart systems.
Charles Doarn
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.